Streptococcus pneumoniae Serotype 3 in Mexico (1994 to 2017): Decrease of the Unusual Clonal Complex 4909 Lineage following PCV13 Introduction-Reference-Cited by-同舟云学术

Streptococcus pneumoniae Serotype 3 in Mexico (1994 to 2017): Decrease of the Unusual Clonal Complex 4909 Lineage following PCV13 Introduction

Published:2019-01 Issue:1 Volume:57 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Echániz-Aviles Gabriela¹,Guerreiro Soraia I.²³,Silva-Costa Catarina²³,Mendes Catarina I.²³,Carriço João André²³^ORCID,Carnalla-Barajas María Noemí¹,Soto-Noguerón Araceli¹,Velazquez-Meza Maria Elena¹,Melo-Cristino José²³,Luévanos-Velazquez Antonio⁴,Martínez-Medina Lucía⁵,Vázquez-Larios María del Rosario⁶,Ramirez Mário²³^ORCID

Affiliation:

1. Centro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico

2. Instituto de Microbiologia, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal

3. Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal

4. Antiguo Hospital Civil Fray Antonio Alcalde, Guadalajara, Mexico

5. Centenario Hospital Miguel Hidalgo de Aguascalientes, Aguascalientes, Mexico

6. Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico

Abstract

Streptococcus pneumoniae expressing serotype 3 has a high virulence and a high case fatality ratio. Most studies of serotype 3 pneumococci have focused on a single lineage, the widespread sequence type 180 (ST180).

Funder

MEC | Fundação para a Ciência e a Tecnologia

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.01354-18

Reference29 articles.

1. Pneumococcal Capsules and Their Types: Past, Present, and Future

2. Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study

3. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance